Mahsa Babaei, Ph.D. is an accomplished biochemist and faculty member at Arak University, Iran. She earned her Ph.D. in Biochemistry from Razi University, focusing on redox-sensitive chitosan-based nanoparticles for targeted doxorubicin delivery in breast cancer therapy. Dr. Babaei has published extensively in international journals on nanomedicine, protein interactions, and biosensing technologies. She has led multiple research projects, contributed as a reviewer for international journals, and conducted numerous workshops on drug delivery systems, molecular docking, and nanotechnology applications. Her work bridges innovative pharmaceutical research and translational therapeutics, advancing targeted drug development and precision medicine